Trial under way for Alumend's device to treat artery disease

Alumend is conducting an early-stage clinical study in New Zealand to test a device that can be used to help treat patients with peripheral arterial disease. The Sioux Falls, S.D.-based startup aims to refine the technology after the initial trial and advance it to U.S. clinical studies, founding member Ron Utecht said at a biotech conference in Chicago.

View Full Article in:

Argus Leader (Sioux Falls, S.D.) (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ